ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Keyword Index

Click a keyword to view all the abstracts on this site tagged with that keyword.

  • [18F]FDG PET
  • 18FDG PET/CT scan
  • 18FDG PET/CT scan and Angiography
  • 18FDG PET/CT scan and cardiac involvement
  • 18FDG PET/CT scan and diagnostic imaging
  • 18FDG PET/CT scan and Musculoskeletal
  • 18FDG PET/CT scan and polymyalgia rheumatica
  • 24-hour activity profile
  • 25 OH D Vitamin insufficiency
  • 25-hydroxyvitamin D
  • 25-hydroxyvitamin D and cardiovascular disease
  • 25-hydroxyvitamin D and hypercalcemia
  • 25-hydroxyvitamin D and pregnancy
  • 25-hydroxyvitamin D and rheumatoid arthritis (RA)
  • 25-hydroxyvitamin D and Vitamin D
  • 3D model
  • 3D model and arthritis
  • 3D model and inflammation
  • 5-HT
  • 8-hydroxydeoxyguanine and DNA
  • A3 Adenosine receptor and gout
  • AA-amyloidosis
  • AA-amyloidosis and familial Mediterranean fever
  • AA-amyloidosis and proteinuria
  • AAV and Diagnostic Tests
  • abaloparatide
  • Abatacept
  • Abatacept and adult-onset Still's disease
  • abatacept and anti-citrullinated protein/peptide antibodies (ACPA)
  • abatacept and anti-TNF therapy
  • Abatacept and autoantibodies
  • abatacept and biomarkers
  • Abatacept and body mass
  • Abatacept and health care cost
  • abatacept and histopathologic
  • Abatacept and juvenile idiopathic arthritis (JIA)
  • Abatacept and macrophages
  • abatacept and magnetic resonance imaging (MRI)
  • abatacept and matrix metalloproteinase (MMP)
  • abatacept and monocytes
  • abatacept and patient-reported outcome measures
  • Abatacept and psoriatic arthritis
  • abatacept and remission
  • abatacept and rheumatoid arthritis
  • Abatacept and rheumatoid arthritis (RA)
  • abatacept and rituximab
  • abatacept and tocilizumab
  • abatacept and treatment
  • Abatacept and tuberculosis
  • abatacept and tumor necrosis factor (TNF)
  • abatacept and ultrasonography
  • ABC and auto-immunity
  • ABP 798 and biosimilars
  • absenteeism
  • Abstracts
  • academic
  • academics
  • Access to care
  • access to care and Electronic Health Record
  • access to care and health disparities
  • access to care and high risk
  • Access to care and inflammatory arthritis
  • Access to care and lupus nephritis
  • access to care and medication
  • access to care and physical therapy
  • access to care and population studies
  • Access to care and primary care
  • Access to care and quality measures
  • Access to care and quality of care
  • access to care and remission
  • Access to care and rheumatologic disease
  • access to care and standards of care
  • Access to care and systemic lupus erythematosus (SLE)
  • accommodation
  • Accreditation
  • ACE
  • ACE-inhibitors
  • ACPA
  • ACPA and cardiovascular disease
  • ACPA and Early Rheumatoid Arthritis
  • ACPA and lung
  • ACPA and osteoclastogenesis
  • ACPA and palindromic rheumatism
  • ACPA and Periodontitis
  • ACPA and psoriatic arthritis
  • ACPA and RANK/RANKL pathway
  • ACPA and rheumatoid arthritis (RA)
  • ACR
  • ACR 20
  • ACR and C-reactive protein (CRP)
  • ACR and Health Assessment Questionnaire
  • ACR and rheumatoid arthritis (RA)
  • ACS and WOMAC
  • Activation triggers
  • activation triggers and dendritic cells
  • active patients and stable patients
  • activities
  • activities of daily living (ADL)
  • activities of daily living (ADL) and myositis
  • activities of daily living (ADL) and systemic sclerosis
  • activity limitation and activity restriction
  • Activity score
  • Activity score and ankylosing spondylitis (AS)
  • activity score and anti-dsDNA
  • activity score and assessment
  • activity score and biomarkers
  • activity score and classification criteria
  • activity score and patient outcomes
  • Activity score and patient questionnaires
  • activity score and patient-reported outcome measures
  • Activity score and polychondritis
  • activity score and polymyalgia rheumatica
  • activity score and prolactin
  • Activity score and psoriatic arthritis
  • activity score and remission
  • Activity score and rheumatoid arthritis (RA)
  • activity score and Still's disease
  • Activity score and systemic lupus erythematosus (SLE)
  • activity score and systemic sclerosis
  • Activity score and total joint replacement
  • activity score and treatment
  • Activity score and uveitis
  • acupressure and clinical trials
  • acupuncture
  • acupuncture and pediatrics
  • acute coronary syndrome (ACS) and left ventricular dysfunction (LVEF)
  • Acute-phase reactants
  • Acute-phase reactants and ankylosing spondylitis (AS)
  • acute-phase reactants and familial Mediterranean fever
  • acute-phase reactants and Janus kinase (JAK)
  • acute-phase reactants and rheumatoid arthritis (RA)
  • acylcarnitines
  • Adalimumab
  • adalimumab and ankylosing spondylitis (AS)
  • adalimumab and anti-CCP antibodies
  • adalimumab and anti-citrullinated protein/peptide antibodies (ACPA)
  • adalimumab and apoptosis
  • Adalimumab and biosimilars
  • adalimumab and economics
  • Adalimumab and health care cost
  • adalimumab and inflammatory arthritis
  • Adalimumab and inflammatory bowel disease (IBD)
  • adalimumab and interleukins (IL)
  • Adalimumab and juvenile arthritis
  • Adalimumab and juvenile idiopathic arthritis (JIA)
  • adalimumab and juvenile idiopathic arthritis-enthesitis (ERA)
  • Adalimumab and juvenile spondylarthropathy
  • adalimumab and matrix metalloproteinase (MMP)
  • adalimumab and messenger RNA (mRNA)
  • adalimumab and methotrexate (MTX)
  • Adalimumab and psoriatic arthritis
  • Adalimumab and rheumatoid arthritis
  • adalimumab and rheumatoid arthritis (RA)
  • Adalimumab and spondylarthritis
  • Adalimumab and spondylarthropathy
  • adalimumab and support
  • Adalimumab and uveitis
  • adam17
  • adaptive immunity
  • adaptive immunity and Cell Signaling
  • adaptive immunity and cutaneous lupus erythematosus
  • adenosine
  • adenosine deaminase 2 and Autoinflammatory Disease
  • Adenosine receptors
  • adenosine receptors and atp
  • Adenosine receptors and collagen
  • adenosine receptors and endothelial cells
  • adenosine receptors and IL-6
  • adenosine receptors and Netrin-1
  • adenosine receptors and osteoblasts
  • Adenosine receptors and osteoclastogenesis
  • adenosine receptors and prosthesis
  • Adenosine receptors and rheumatoid arthritis (RA)
  • adenosine receptors and salivary hypofunction
  • Adenosine receptors and scleroderma
  • adenosine receptors and Sema4D
  • adherence
  • Adherence Barrier
  • Adhesion molecules
  • adhesion molecules and epigenetics
  • Adhesion molecules and inflammation
  • adhesion molecules and monocytes
  • adhesion molecules and neutrophils
  • adhesion molecules and rheumatoid arthritis (RA)
  • adhesion molecules and signal transduction
  • Adhesion, Adhesion molecules
  • adhesive capsulitis
  • Adipocytokines
  • Adipocytokines and rheumatoid arthritis (RA)
  • Adipocytokines and systemic lupus erythematosus (SLE)
  • Adipocytokines and systemic sclerosis
  • Adipokines
  • adipokines and biomarkers
  • Adipokines and osteoarthritis
  • adipokines and rheumatoid arthritis
  • Adipokines and rheumatoid arthritis (RA)
  • adipose tissue
  • adipose tissue and adipokines
  • adipose tissue and bone density
  • adipose tissue and sarcopenia
  • [1]
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »
  • | Last
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences